• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外用脂质体两性霉素B与病灶内注射葡甲胺锑酸盐(葡糖胺锑钠)治疗皮肤利什曼病的疗效比较

Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis.

作者信息

Layegh Pouran, Rajabi Omid, Jafari Mahmoud Reza, Emamgholi Tabar Malekshah Parisa, Moghiman Toktam, Ashraf Hami, Salari Roshanak

机构信息

Research Center for Skin Diseases & Cutaneous Leishmaniasis, Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

出版信息

J Parasitol Res. 2011;2011:656523. doi: 10.1155/2011/656523. Epub 2011 Nov 24.

DOI:10.1155/2011/656523
PMID:22174993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3228299/
Abstract

Background. Topical treatment of cutaneous leishmaniasis is an attractive alternative avoiding toxicities of parenteral therapy while being administered through a simple painless route. Recently liposomal formulations of amphotericin B have been increasingly used in the treatment of several types of leishmaniasis. Aims. The efficacy of a topical liposomal amphotericin B formulation was compared with intralesional glucantime in the treatment of cutaneous leishmaniasis. Methods. From 110 patients, the randomly selected 50 received a topical liposomal formulation of amphotericin B into each lesion, 3-7 drops twice daily, according to the lesion's size and for 8 weeks. The other group of 60 patients received intralesional glucantime injection of 1-2 mL once a week for the same period. The clinical responses and side effects of both groups were evaluated weekly during the treatment course. Results. Per-protocol analysis showed no statistically significant difference between the two groups (P = 0.317, 95% confidence interval (CI) = 1.610 (0.632-4.101)). Moreover, after intention-to-treat analysis, the same results were seen (P = 0.650, 95% CI = 0.1.91 (0.560-2.530)). Serious post treatment side effects were not observed in either group. Conclusions. Topical liposomal amphotericin B has the same efficacy as intralesional glucantime in the treatment of cutaneous leishmaniasis.

摘要

背景。皮肤利什曼病的局部治疗是一种有吸引力的替代方法,可避免肠胃外治疗的毒性,且给药途径简单无痛。最近,两性霉素B脂质体制剂越来越多地用于治疗几种类型的利什曼病。目的。比较局部用两性霉素B脂质体制剂与病灶内注射葡糖胺聚糖治疗皮肤利什曼病的疗效。方法。从110例患者中随机选取50例,根据病灶大小,每个病灶每日两次给予3 - 7滴局部用两性霉素B脂质体制剂,持续8周。另一组60例患者在同一时期每周一次病灶内注射1 - 2 mL葡糖胺聚糖。在治疗过程中每周评估两组的临床反应和副作用。结果。符合方案分析显示两组之间无统计学显著差异(P = 0.317,95%置信区间(CI) = 1.610(0.632 - 4.101))。此外,意向性分析后也得到相同结果(P = 0.650,95% CI = 0.1.91(0.560 - 2.530))。两组均未观察到严重的治疗后副作用。结论。局部用两性霉素B脂质体制剂在治疗皮肤利什曼病方面与病灶内注射葡糖胺聚糖具有相同的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fed7/3228299/7c09127177f8/JPR2011-656523.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fed7/3228299/bad776c7266a/JPR2011-656523.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fed7/3228299/7c09127177f8/JPR2011-656523.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fed7/3228299/bad776c7266a/JPR2011-656523.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fed7/3228299/7c09127177f8/JPR2011-656523.002.jpg

相似文献

1
Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis.外用脂质体两性霉素B与病灶内注射葡甲胺锑酸盐(葡糖胺锑钠)治疗皮肤利什曼病的疗效比较
J Parasitol Res. 2011;2011:656523. doi: 10.1155/2011/656523. Epub 2011 Nov 24.
2
Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.局部用脂质体阿奇霉素治疗急性皮肤利什曼病。
Dermatol Ther. 2016 Sep;29(5):358-363. doi: 10.1111/dth.12357. Epub 2016 Apr 12.
3
Combination of topical liposomal amphotericin B and Glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by : study protocol for a randomized, controlled trial.局部用两性霉素B脂质体与葡聚糖铁组合与单独使用葡聚糖铁治疗由……引起的人源性皮肤利什曼病(ACL)的比较:一项随机对照试验的研究方案
Iran J Microbiol. 2021 Oct;13(5):718-723. doi: 10.18502/ijm.v13i5.7440.
4
Pilot study of safety and efficacy of topical liposomal amphotericin B for cutaneous leishmaniasis caused by Leishmania major in Islamic Republic of Iran.伊朗伊斯兰共和国局部应用脂质体两性霉素B治疗硕大利什曼原虫引起的皮肤利什曼病的安全性和有效性的初步研究。
East Mediterr Health J. 2022 Sep 29;28(9):658-663. doi: 10.26719/emhj.22.070.
5
Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis.外用蜂蜜联合病灶内注射葡糖胺聚糖治疗皮肤利什曼病的效果
BMC Complement Altern Med. 2007 Apr 27;7:13. doi: 10.1186/1472-6882-7-13.
6
Evaluation of the efficacy of intralesional Glucantime plus niosomal zinc sulphate in comparison with intralesional Glucantime plus cryotherapy in the treatment of acute cutaneous leishmaniasis, a randomized clinical trial.病灶内注射葡糖胺锑钠加硫酸锌脂质体与病灶内注射葡糖胺锑钠加冷冻疗法治疗急性皮肤利什曼病疗效的比较:一项随机临床试验
J Parasit Dis. 2018 Dec;42(4):616-620. doi: 10.1007/s12639-018-1044-5. Epub 2018 Oct 13.
7
Comparative assessment of interventions for treating cutaneous leishmaniasis: A network meta-analysis of randomized clinical trials.比较治疗皮肤利什曼病干预措施的效果:一项随机临床试验的网络荟萃分析。
Acta Trop. 2021 Aug;220:105944. doi: 10.1016/j.actatropica.2021.105944. Epub 2021 May 3.
8
Efficacy of adjunctive topical liposomal clarithromycin on systemic Glucantime in Old World cutaneous leishmaniasis: a pilot clinical study.辅助局部应用脂质体克拉霉素对全身使用葡糖胺锑钠治疗旧世界皮肤利什曼病的疗效:一项初步临床研究。
Front Pharmacol. 2023 Nov 7;14:1280240. doi: 10.3389/fphar.2023.1280240. eCollection 2023.
9
A Case Series of 36 Patients Treated for Old World Cutaneous leishmaniasis.36例治疗的旧世界皮肤利什曼病病例系列
J Clin Aesthet Dermatol. 2024 Jul;17(7):38-42.
10
Comparison of intralesional two percent zinc sulfate and glucantime injection in treatment of acute cutaneous leishmaniasis.病灶内注射2%硫酸锌与葡糖胺注射治疗急性皮肤利什曼病的比较
Indian J Dermatol. 2012 Mar;57(2):118-22. doi: 10.4103/0019-5154.94279.

引用本文的文献

1
Biocompatibility and Effectiveness of Amphotericin B-Loaded Metal-Organic Structures (AmB-ZIF-8) as Dermal Drug Transporters in Experimental Cutaneous Leishmaniasis.负载两性霉素B的金属有机结构(AmB-ZIF-8)作为实验性皮肤利什曼病皮肤药物转运体的生物相容性和有效性
J Exp Pharmacol. 2025 May 30;17:269-286. doi: 10.2147/JEP.S511808. eCollection 2025.
2
A Case Series of 36 Patients Treated for Old World Cutaneous leishmaniasis.36例治疗的旧世界皮肤利什曼病病例系列
J Clin Aesthet Dermatol. 2024 Jul;17(7):38-42.
3
Local amphotericin B therapy for Cutaneous Leishmaniasis: A systematic review.

本文引用的文献

1
Systemic meglumine antimoniate in acute cutaneous leishmaniasis: children versus adults.全身性喷他脒治疗急性皮肤利什曼病:儿童与成人。
Am J Trop Med Hyg. 2011 Apr;84(4):539-42. doi: 10.4269/ajtmh.2011.10-0002.
2
Evaluation of PCR assay in diagnosis and identification of cutaneous leishmaniasis: a comparison with the parasitological methods.聚合酶链反应检测法在皮肤利什曼病诊断与鉴定中的评估:与寄生虫学方法的比较
Parasitol Res. 2008 Oct;103(5):1159-62. doi: 10.1007/s00436-008-1111-4. Epub 2008 Jul 25.
3
Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial.
局部两性霉素 B 治疗皮肤利什曼病:系统评价。
PLoS Negl Trop Dis. 2024 Apr 16;18(4):e0012127. doi: 10.1371/journal.pntd.0012127. eCollection 2024 Apr.
4
Amphotericin-B in Dermatology.皮肤科中的两性霉素B。
Indian Dermatol Online J. 2022 Jan 24;13(1):152-158. doi: 10.4103/idoj.idoj_573_21. eCollection 2022 Jan-Feb.
5
Evaluation of the Interventional Approaches in the Management of Cutaneous Leishmaniasis in Jazan: An Observational Study.吉赞地区皮肤利什曼病管理中干预方法的评估:一项观察性研究
Ann Dermatol. 2018 Oct;30(5):575-580. doi: 10.5021/ad.2018.30.5.575. Epub 2018 Aug 28.
6
Therapeutic advances in the topical treatment of cutaneous leishmaniasis: A review.皮肤利什曼病的局部治疗的治疗进展:综述。
PLoS Negl Trop Dis. 2021 Mar 3;15(3):e0009099. doi: 10.1371/journal.pntd.0009099. eCollection 2021 Mar.
7
Antileishmanial activity and immune modulatory effects of benzoxonium chloride and its entrapped forms in niosome on .苯扎氯铵及其在非离子表面活性剂囊泡中的包封形式对利什曼原虫的抗利什曼活性和免疫调节作用 。 需注意,你提供的原文似乎不完整,结尾处“on.”后面应该还有具体内容。
J Parasit Dis. 2019 Sep;43(3):406-415. doi: 10.1007/s12639-019-01105-7. Epub 2019 Mar 29.
8
Lipsosomal amphotericin B: a review of its properties, function, and use for treatment of cutaneous leishmaniasis.脂质体两性霉素B:其性质、功能及用于治疗皮肤利什曼病的综述
Res Rep Trop Med. 2019 Apr 26;10:11-18. doi: 10.2147/RRTM.S200218. eCollection 2019.
9
Interventions for Old World cutaneous leishmaniasis.旧世界皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2017 Dec 1;12(12):CD005067. doi: 10.1002/14651858.CD005067.pub5.
10
Interventions for Old World cutaneous leishmaniasis.旧世界皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2017 Nov 17;11(11):CD005067. doi: 10.1002/14651858.CD005067.pub4.
光动力疗法与外用巴龙霉素治疗旧世界皮肤利什曼病的疗效比较:一项安慰剂对照的随机临床试验。
Clin Exp Dermatol. 2006 Sep;31(5):634-7. doi: 10.1111/j.1365-2230.2006.02182.x. Epub 2006 Jun 15.
4
Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites.由于耐药性热带利什曼原虫寄生虫,伊朗皮肤利什曼病对葡糖胺锑治疗无反应。
PLoS Med. 2006 May;3(5):e162. doi: 10.1371/journal.pmed.0030162. Epub 2006 Apr 18.
5
Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana.墨西哥利什曼原虫稳定的两性霉素抗性无鞭毛体和前鞭毛体的产生及特性研究
Antimicrob Agents Chemother. 2005 Aug;49(8):3274-80. doi: 10.1128/AAC.49.8.3274-3280.2005.
6
Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis.脂质体两性霉素B成功治疗巴西利什曼原虫皮肤利什曼病。
Br J Dermatol. 2005 Jul;153(1):203-5. doi: 10.1111/j.1365-2133.2005.06670.x.
7
Atypical multifocal cutaneous leishmaniasis in an immunocompetent patient treated by liposomal amphotericin B.脂质体两性霉素B治疗免疫功能正常患者的非典型多灶性皮肤利什曼病
J Infect. 2005 Dec;51(5):e261-4. doi: 10.1016/j.jinf.2005.03.012. Epub 2005 Jun 2.
8
Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients.在两名免疫功能低下的患者中,使用两性霉素B脂质制剂成功治疗皮肤利什曼病。
Acta Trop. 2004 Oct;92(2):127-32. doi: 10.1016/j.actatropica.2004.06.006.
9
A novel method for the preparation of liposomes: freeze drying of monophase solutions.一种制备脂质体的新方法:单相溶液的冷冻干燥。
J Pharm Sci. 2004 Jun;93(6):1403-14. doi: 10.1002/jps.20055.
10
Topical treatment of persistent cutaneous leishmaniasis with ethanolic lipid amphotericin B.用乙醇脂质两性霉素B局部治疗持续性皮肤利什曼病。
Pediatr Infect Dis J. 2003 Jun;22(6):567-9.